Back to search

Pathogenesis and Treatment of Pretibial Myxedema

Data up to Jan 2025

Published1987
Citations92
References28

Total Citations Per Year

Abstract

References (28)

Ruthenium red and violet. II. Fine structural localization in animal tissues

1971 • 862 citations

Isolation and Identification of the Long-Acting Thyroid Stimulator and Its Relation to Hyperthyroidism and Circumscribed Pretibial Myxedema1

1964 • 335 citations

INSULIN-LIKE GROWTH FACTOR-I STIMULATES THE GROWTH OF RAT THYROID CELLS IN CULTURE AND SYNERGIZES THE STIMULATION OF DNA SYNTHESIS INDUCED BY TSH AND GRAVES′-IgG

1986 • 286 citations

The Generation of Insulin-Like Growth Factor-1—Sensitive Cells by Growth Hormone Action

1986 • 192 citations

Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease.

1982 • 166 citations

Clinical Significance of Assay of Thyroid-Stimulating Antibody in Graves' Disease

1980 • 161 citations

Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.

1979 • 120 citations

Ability of Monoclonal Antibodies to the Thyrotropin Receptor to Increase Collagen Synthesis in Human Fibroblasts: An Assay which Appears to Measure Exophthalmogenic Immunoglobulins in Graves' Sera

1986 • 112 citations

Stimulation of Fibroblast Biosynthetic Activity by Serum of Patients with Pretibial Myxedema

1978 • 110 citations

Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: Possible functional and clinical significance

1986 • 98 citations

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease

1967 • 89 citations

Therapy with Occlusive Dressings of Pretibial Myxedema with Fluocinolone Acetonide1

1967 • 63 citations

Pretibial Myxedema and Nonthyrotoxic Thyroid Disease

1973 • 61 citations

Immunologically Mediated Cytotoxicity against Human Eye Muscle Cells in Graves’ Ophthalmopathy*

1986 • 59 citations

Relationship of Long-Acting Thyroid Stimulator to Pretibial Myxedema

1970 • 45 citations

Preradial Myxedema in Thyroid Disease

1981 • 45 citations

Intralesional Triamcinolone Therapy for Pretibial Myxedema

1975 • 44 citations

Ultrastructural and Immunological Findings in Graves' Disease with Pretibial Myxedema*

1980 • 38 citations

The Acquired Cutaneous Mucinoses

1984 • 37 citations

Altered Skin Elastic Fibers in Hypothyroid Myxedema and Pretibial Myxedema

1985 • 36 citations

Corticoid Therapy for Pretibial Myxedema

1967 • 30 citations

Ultrastructure of localized myxedema

1976 • 24 citations

Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema

1982 • 23 citations

An ultrastructural study of pretibial myxedema utilizing improved ruthenium red stain

1984 • 13 citations

Chemical characterization of high buoyant density proteoglycan accumulated in the affected skin of pretibial myxedema of Graves' disease.

1986 • 12 citations

Pretibial myxedema (elephantiasic form): treatment with cytotoxic therapy

1983 • 10 citations

Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves’ disease associated with localized myxedema

1984 • 7 citations

STUDY ON THE ULTRASTRUCTURE AND MUCIN PRODUCTION IN PRETIBIAL MYXEDEMA

1971 • 5 citations

Cited By (0)

Loading...
Pathogenesis and Treatment of Pretibial Myxedema (1987) – Endocrinology and Metabolism Clinics of North America | Metascience Observatory Explorer